Good Morning America
Matthew Knowles shares his story with Good Morning America and discusses male breast cancer and BRCA. Basser Executive Director Susan Domchek, MD, was interviewed for the piece and shares that "men with BRCA2 mutations have a particular increased risk of male breast cancer" and other cancers.
Basser Executive Director Susan Domchek, MD, has been featured as one of Philadelphia Magazine's 2019 Breast Health Champions. In this interview with her, she discusses the role of medical oncologists, hereditary cancer, and what both men and women should know about their potential risk for breast cancer.
WOSU Radio’s “All Sides with Ann Fisher” interviewed Payal D. Shah, MD, an assistant professor of Hematology-Oncology and a member of the Basser Center, about breast cancer in men, genetic risks, and what patients should know.
Basser Executive Director Susan Domchek, MD, discusses the importance of knowing your family health history on Real Pink, the Susan G. Komen podcast.
Susan Domchek, MD, Executive Director of the Basser Center, discusses the potential benefits of biosimilars in oncology. Biosimilars are like "generic" medications; they are officially approved versions of innovative, original products.
Penn Medicine News
Douglas Easton, PhD, and Antonis Antoniou, PhD, have been named recipients of the seventh annual Basser Global Prize. Easton and Antoniou are both professors in the department of Public Health and Primary Care at the University of Cambridge, and members of the Cancer Research UK Cambridge Centre.
Journal of the American Medical Association
For the Journal of the American Medical Association, Basser executive director Susan Domchek, MD, and Memorial Sloan Kettering's Mark Robson, MD, discuss limitations around the new United States Preventive Services Task Force guidelines for BRCA genetic testing.
American Society of Clinical Oncology Journal
Basser Center genetic counselors and investigators teamed up to analyze publicly available data for genes in which mutations are implicated in germline cancer susceptibility and establish a pipeline to automate clinical referral for evaluation of tumor-only genetic profiling.
Basser Center founders Mindy and Jon Gray have announced a further $25 million in funding for BRCA-related research. The grants will be split among seven research teams across the globe.
Penn Medicine News
Katherine L. Nathanson, MD, has been awarded a $3 million research grant from the Gray Foundation, which will support Nathanson and her team as they study new approaches to understanding immune function both in healthy BRCA mutation carriers and BRCA-related cancers.
New York Post
Basser Young Leadership co-chair Erika Stallings is featured in a body awareness piece from the New York Post, where she discusses life after a preventive mastectomy.
Reader's Digest shares a helpful list of what doctors wish you knew about breast cancer and genetic testing (including a Basser Center mention).
People En Espanol
Alejandra Campoverdi shares her story with People En Espanol and discusses her BRCA2 mutation, her recent preventative mastectomy, and her new collaboration with the Basser Center: LATINX & BRCA, the first BRCA-related awareness campaign focused on the Latinx community.
Journal of Clinical Oncology
In the Journal of Clinical Oncology, Basser Executive Director Susan Domchek, MD, discusses at-home genetic testing and the FDA’s regulatory language, which might confuse not only consumers, but also medical providers who are asked to interpret results and make clinical recommendations.
National Cancer Institute
Susan Domchek, MD, executive director of the Basser Center, discusses the state of research showing PARP inhibitors can be effective for pancreatic patients with BRCA mutations.
Main Line Times
Mainline Media News profiles the work of Dr. Ronny Drapkin, the Basser Center's Director of Gynecologic Cancer Research.
Penn Medicine News
Researchers at Penn Medicine and University of Leeds, co-led by the Basser's Roger Greenberg, MD, PhD, have deciphered the structure of a multipart, molecular complex that is also responsible for regulating the immune system and have found new molecular targets for fighting autoimmunity.